RYTM is Rhythm Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $102.74. Market cap: $7.07B. Capital Quality Rank: 90/100 — Elite compounder.
Stock snapshot
| Price | $102.74 |
| Market cap | $7.07B |
| Sector | Healthcare |
| Exchange | NGM |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 90 / 100 · Elite compounder |
| ROIC (TTM) | -81.7% |
| Revenue CAGR (3y) | 100.2% |
| Shareholder buyback yield | -6.14% |
| Altman Z-score zone | Safe |
About RYTM
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Related non-dividend companies
Other non-dividend stocks investors research alongside RYTM. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is RYTM's current stock price?
RYTM (Rhythm Pharmaceuticals, Inc.) is currently trading at $102.74.
Does RYTM pay a dividend?
RYTM (Rhythm Pharmaceuticals, Inc.) does not currently pay a regular dividend.
What is RYTM's Capital Quality Rank?
RYTM has a Capital Quality Rank of 90/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track RYTM in DiviDrip
Add RYTM to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search RYTM and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.